Hepatitis a virus antigen - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
TWINRIX JUNIOR (combined hepatitis A & hepatitis B vaccine) 0.5 mL injection pre-filled syringe thiomersal & preservative free
AUST R: 140576
Active ingredients:
Hepatitis a virus antigen
Hepatitis B surface antigen recombinant

Dosage form:
Injection, suspension

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

Deletion from market:
01 Jul 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability